Stay updated on ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page
- ChecktodayChange DetectedThe page now lists expanded recruitment locations, including US states (Colorado, Massachusetts, Missouri, New York, North Carolina, Rhode Island, Tennessee, Texas) and Australian regions (Queensland, South Australia, Victoria, Western Australia).SummaryDifference1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.3.2 has been added and Revision: v3.2.0 has been removed.SummaryDifference0.0%

- Check36 days agoChange DetectedRemoved the banner about funding-related operating status and links to cc.nih.gov and opm.gov from the study page.SummaryDifference0.3%

- Check50 days agoChange DetectedNo significant changes detected between the two screenshots; the study record details and layout appear unchanged.SummaryDifference0.3%

- Check79 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference4%

- Check86 days agoChange DetectedShift focus from broad public health topics to drug development and evaluation topics, accompanied by a version update to v3.1.0. De-emphasizes public health and mass screening terms.SummaryDifference1%

Stay in the know with updates to ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page.